We are live on ! Find out more
VANI icon

Vivani Medical

32 hedge funds and large institutions have $3.62M invested in Vivani Medical in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

0.25% less ownership

Funds ownership: 7.24%6.99% (-0.25%)

3% less funds holding

Funds holding: 3332 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

19% less capital invested

Capital invested by funds: $4.45M → $3.62M (-$825K)

Holders
32
Holders Change
-1
Holders Change %
-3.03%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
5
Reduced
5
Closed
7
Calls
$13K
Puts
Net Calls
+$13K
Net Calls Change
-$1K

VANI Hedge Fund Activity: Q3 2023 in Review

32 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q3 2023, worth a combined $3.62M — down 19% from $4.45M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of VANI and 6 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 5 added.

The largest buyer was Geode Capital Management, adding an estimated $60.1K. The largest seller was BlackRock, cutting an estimated $172K.

  • 32 institutional investors held Vivani Medical (VANI) as of Q3 2023, down from 33 in Q2 2023.
  • Funds reported $3.62M of Vivani Medical stock for Q3 2023, down 19% quarter-over-quarter.
  • 6 funds opened new Vivani Medical positions in Q3 2023 and 7 closed out, a net change of -1 holder.
  • The largest Vivani Medical buyer in Q3 2023 was Geode Capital Management, an estimated $60.1K added.
  • The largest Vivani Medical seller in Q3 2023 was BlackRock, an estimated $172K sold.

Based on aggregated 13F filings for Q3 2023.